(19)
(11) EP 1 140 070 A1

(12)

(43) Date of publication:
10.10.2001 Bulletin 2001/41

(21) Application number: 99962419.0

(22) Date of filing: 22.12.1999
(51) International Patent Classification (IPC)7A61K 31/40, A61P 3/00
(86) International application number:
PCT/GB9904/374
(87) International publication number:
WO 0038/675 (06.07.2000 Gazette 2000/27)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 23.12.1998 GB 9828640

(71) Applicant: SMITHKLINE BEECHAM PLC
Brentford,Middlesex TW8 9EP (GB)

(72) Inventors:
  • COGHLAN, Matthew PaulSmithKline Beecham Pharm.
    Harlow,Essex CM19 5AW (GB)
  • HOLDER, Julie Caroline,SmithKline Beecham Pharm.
    Harlow,Essex CM19 5AW (GB)
  • REITH, Alastair David,SmithKline Beecham Pharm.
    Harlow,Essex CM19 5AW (GB)
  • SMITH, David Glynn,SmithKline Beecham Pharm.
    Harlow,Essex CM19 5AW (GB)

(74) Representative: Rutter, Keith et al
GlaxoSmithKline,Two New Horizons Court
Brentford, Middlesex TW8 9EP
Brentford, Middlesex TW8 9EP (GB)

   


(54) TREATMENT OF CONDITIONS WITH A NEED FOR THE INHIBITION OF GSK-3